Edition:
United States

Getinge AB (GETIb.ST)

GETIb.ST on Stockholm Stock Exchange

182.20SEK
26 May 2017
Change (% chg)

2.10kr (+1.17%)
Prev Close
180.10kr
Open
180.00kr
Day's High
182.60kr
Day's Low
179.50kr
Volume
828,835
Avg. Vol
1,072,305
52-wk High
182.60kr
52-wk Low
136.90kr

GETIb.ST

Chart for GETIb.ST

About

Getinge AB is a Sweden-based company active in the healthcare sector. It provides products and services for intensive care units, sterilization centers, elderly care and companies and institutions active in the life sciences area. Its operations are divided into three business areas: The Medical Systems business area offers... (more)

Overall

Beta: 1.14
Market Cap(Mil.): kr40,518.24
Shares Outstanding(Mil.): 222.38
Dividend: 2.00
Yield (%): 1.10

Financials

  GETIb.ST Industry Sector
P/E (TTM): 32.05 31.44 17.41
EPS (TTM): 5.69 -- --
ROI: 2.98 12.84 -5.42
ROE: 6.96 15.33 -4.68

UPDATE 1-Getinge Q1 beats expectations as savings kick in, shares soar

* Says can't rule out further costs related to FDA probe (Adds detail, background, share price)

Apr 25 2017

Getinge Q1 core profit beats expectations

STOCKHOLM, April 25 Swedish medical technology firm Getinge reported on Tuesday a first-quarter core profit above expectations and repeated guidance for a slightly positive organic sales growth for the full year, sending its shares higher.

Apr 25 2017

BRIEF-Getinge chief financial officer to leave in November

* Getinge says Reinhard Mayer, chief financial officer of Getinge, has decided to leave company for family reasons

Apr 20 2017

UPDATE 1-Getinge Q4 profit lags expectations, awaits FDA view on quality controls

Jan 26 Medical technology firm Getinge posted a fourth-quarter core profit below market forecasts on Thursday and said it was still awaiting reply from the U.S. Food and Drug Administration (FDA) on work to improve quality controls at one of its plants.

Jan 26 2017

BRIEF-Getinge Q4 core profit below expectations

* Getinge q4 order intake increased by 3.1% to sek 8,582 m (8,326). Order intake declined organically by 1.1%.

Jan 26 2017

More From Around the Web

Earnings vs. Estimates